Tirzepatide is a synthetic peptide that functions as a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. It is designed to influence metabolic signaling pathways involved in glucose regulation, insulin secretion, appetite modulation, and energy balance.